Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19

Public

Published in Antimicrobial Agents and Chemotherapy • Apr 21, 2020

Authors:

Markus Hoffmann

Simon Schroeder

Hannah Kleine‐Weber

Abstract

Funder: \n Bundesministerium für Bildung und Forschung\n https://doi.org/10.13039/501100002347

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

(0)

No comments yet

Be the first to share your thoughts!